TReatment of Pulmonary Hypertension Group II Study
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Richard Cheng, MD
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Richard Cheng, MD
Dr. Richard Cheng is a cardiologist who specializes in the comprehensive care of patients with heart failure. Having trained in both advanced heart failure and interventional cardiology, his approach combines medical therapy optimization with minimally invasive surgeries and novel devices that can improve heart function.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- SoniVie Inc.
- ID
- NCT03611270
- Study Type
- Interventional
- Participants
- Expecting 15 study participants
- Last Updated